Dihydroartemisinin represses oral squamous cell carcinoma progression through downregulating mitochondrial calcium uniporter

References

• Dan H, Liu S, Liu J, et al. RACK1 promotes cancer progression by increasing the M2/M1 macrophage ratio via the NF-κB pathway in oral squamous cell carcinoma. Mol Oncol. 2020;14(4):795–807.
   PubMed Web of Science ®Google Scholar
• Lu Y, Zheng Z, Yuan Y, et al. The emerging role of exosomes in oral squamous cell carcinoma. Front Cell Dev Biol. 2021;9:628103.
   PubMed Web of Science ®Google Scholar
• Zhang L, Meng X, Zhu XW, et al. Long non-coding RNAs in Oral squamous cell carcinoma: biologic function, mechanisms and clinical implications. Mol Cancer. 2019;18(1):102.
   PubMed Web of Science ®Google Scholar
• Weiße J, Rosemann J, Krauspe V, et al. RNA-binding proteins as regulators of migration, invasion and metastasis in oral squamous cell carcinoma. Int J Mol Sci. 2020; 211: 6835.
   PubMed Web of Science ®Google Scholar
• Weckx A, Riekert M, Grandoch A, et al. Time to recurrence and patient survival in recurrent oral squamous cell carcinoma. Oral Oncol. 2019;94:8–13.
   PubMed Web of Science ®Google Scholar
• Huang F, Xin C, Lei K, et al. Noncoding RNAs in oral premalignant disorders and oral squamous cell carcinoma. Cell Oncol (Dordr). 2020;43(5):763–777.
   PubMed Web of Science ®Google Scholar
• Yang Y, Chen D, Liu H, et al. Increased expression of lncRNA CASC9 promotes tumor progression by suppressing autophagy-mediated cell apoptosis via the AKT/mTOR pathway in oral squamous cell carcinoma. Cell Death Dis. 2019;10(2):41.
   PubMed Web of Science ®Google Scholar
• Liu Y, Jin M, Wang Y, et al. MCU-induced mitochondrial calcium uptake promotes mitochondrial biogenesis and colorectal cancer growth. Signal Transduct Target Ther. 2020;5(1):59.
   PubMed Web of Science ®Google Scholar
• Delierneux C, Kouba S, Shanmughapriya S, et al. Mitochondrial calcium regulation of redox signaling in cancer. Cells. 2020;9(2):432.
   PubMed Web of Science ®Google Scholar
• Woods JJ, Wilson JJ. Inhibitors of the mitochondrial calcium uniporter for the treatment of disease. Curr Opin Chem Biol. 2020;55:9–18.
   PubMed Web of Science ®Google Scholar
• Cui C, Yang J, Fu L, et al. Progress in understanding mitochondrial calcium uniporter complex-mediated calcium signalling: a potential target for cancer treatment. Br J Pharmacol. 2019;176(9):1190–1205.
   PubMed Web of Science ®Google Scholar
• Vultur A, Gibhardt CS, Stanisz H, et al. The role of the mitochondrial calcium uniporter (MCU) complex in cancer. Pflugers Arch. 2018;470(8):1149–1163.
   PubMed Web of Science ®Google Scholar
• Koval OM, Nguyen EK, Santhana V, et al. Loss of MCU prevents mitochondrial fusion in G(1)-S phase and blocks cell cycle progression and proliferation. Sci Signal. 2019;12(579):eaav1439.
   PubMed Web of Science ®Google Scholar
• Zheng X, Lu S, He Z, et al. MCU-dependent negative sorting of miR-4488 to extracellular vesicles enhances angiogenesis and promotes breast cancer metastatic colonization. Oncogene. 2020;39(46):6975–6989.
   PubMed Web of Science ®Google Scholar
• Zeng F, Chen X, Cui W, et al. RIPK1 binds MCU to mediate induction of mitochondrial Ca(2+) uptake and promotes colorectal oncogenesis. Cancer Res. 2018;78:2876–2885.
   PubMed Web of Science ®Google Scholar
• Ren T, Zhang H, Wang J, et al. MCU-dependent mitochondrial Ca(2+) inhibits NAD(+)/SIRT3/SOD2 pathway to promote ROS production and metastasis of HCC cells. Oncogene. 2017;36(42):5897–5909.
   PubMed Web of Science ®Google Scholar
• Wu R, Zuo W, Xu X, et al. MCU that is transcriptionally regulated by Nrf2 augments malignant biological behaviors in oral squamous cell carcinoma cells. Biomed Res Int. 2021;2021:6650791.
   PubMed Web of Science ®Google Scholar
• Chaib I, Cai X, Llige D, et al. Osimertinib and dihydroartemisinin: a novel drug combination targeting head and neck squamous cell carcinoma. Ann Transl Med. 2019;7(22):651.
   PubMed Web of Science ®Google Scholar
• Chen R, Lu X, Li Z, et al. Dihydroartemisinin prevents progression and metastasis of head and neck squamous cell carcinoma by inhibiting polarization of macrophages in tumor microenvironment. Onco Targets Ther. 2020;13:3375–3387.
   PubMed Web of Science ®Google Scholar
• Wang W, Sun Y, Li X, et al. Dihydroartemisinin prevents distant metastasis of laryngeal carcinoma by Inactivating STAT3 in cancer stem cells. Med Sci Monit. 2020;26:e922348.
   PubMed Web of Science ®Google Scholar
• Colak S, Ten Dijke P. Targeting TGF-β signaling in cancer. Trends Cancer. 2017;3:56–71.
   PubMed Web of Science ®Google Scholar
• Zhu X, Chen L, Liu L, et al. EMT-mediated acquired EGFR-TKI resistance in NSCLC: mechanisms and strategies. Front Oncol. 2019;9:1044.
   PubMed Web of Science ®Google Scholar
• Chai AWY, Lim KP, Cheong SC. Translational genomics and recent advances in oral squamous cell carcinoma. Semin Cancer Biol. 2020;61:71–83.
   PubMed Web of Science ®Google Scholar
• Prat A, Navarro A, Paré L, et al. Immune-related gene expression profiling after PD-1 blockade in non-small cell lung carcinoma, head and neck squamous cell carcinoma, and melanoma. Cancer Res. 2017;77:3540–3550.
   PubMed Web of Science ®Google Scholar
• Solomon B, Young RJ, Rischin D. Head and neck squamous cell carcinoma: genomics and emerging biomarkers for immunomodulatory cancer treatments. Semin Cancer Biol. 2018;52:228–240.
   PubMed Web of Science ®Google Scholar
• Sun Y, Li M, Liu G, et al. The function of Piezo1 in colon cancer metastasis and its potential regulatory mechanism. J Cancer Res Clin Oncol. 2020;146(5):1139–1152.
   PubMed Web of Science ®Google Scholar
• Li CJ, Lin HY, Ko CJ, et al. A novel biomarker driving poor-prognosis liver cancer: overexpression of the mitochondrial calcium gatekeepers. Biomedicines. 2020;9(1):8.
   PubMed Web of Science ®Google Scholar
• Rao G, Dwivedi SKD, Zhang Y, et al. MicroRNA-195 controls MICU1 expression and tumor growth in ovarian cancer. EMBO Rep. 2020;21:e48483.
   PubMed Web of Science ®Google Scholar
• Wang Y, Jia RZ, Diao S, et al. miRNA-101 targets TGF-βR1 to retard the progression of oral squamous cell carcinoma. Oncol Res. 2020;28:203–212.
   PubMed Web of Science ®Google Scholar
• Zhang P, Liu Y, Li C, et al. LncRNA PAPAS promotes oral squamous cell carcinoma by upregulating transforming growth factor-β1. J Cell Biochem. 2019;120(9):16120–16127.
   PubMed Web of Science ®Google Scholar
• Xuan YZ, Jin CR, Yang KJ. TGF-β downregulation overcomes gemcitabine resistance in oral squamous cell carcinoma. Cancer Biomark. 2020;29:179–187.
   PubMed Web of Science ®Google Scholar
• Parikh AS, Puram SV, Faquin WC, et al. Immunohistochemical quantification of partial-EMT in oral cavity squamous cell carcinoma primary tumors is associated with nodal metastasis. Oral Oncol. 2019;99:104458.
   PubMed Web of Science ®Google Scholar
• Bai Y, Sha J, Kanno T. The role of carcinogenesis-related biomarkers in the Wnt pathway and their effects on Epithelial-Mesenchymal Transition (EMT) in oral squamous cell carcinoma. Cancers (Basel). 2020;12(3) ;555.
   PubMed Web of Science ®Google Scholar
• Jia L, Song Q, Zhou C, et al. Dihydroartemisinin as a Putative STAT3 Inhibitor, Suppresses the Growth of Head and Neck Squamous Cell Carcinoma by Targeting Jak2/STAT3 Signaling. PLoS One. 2016;11(1):e0147157.
   PubMed Web of Science ®Google Scholar